The development of an innovative interactive online platform for clinical trials

点击翻译按钮获取中文摘要

The proposed solution will be the development of an intelligent cloud-based recruitment andcommunication platform for connecting healthcare professionals, scientists, research nurses,trial coordinators and patients for better knowledge access and transfer on clinical trials.Called “www.youtreatmentchoices.com”, the platform allows patients to watch and listen tovideos of research doctors explaining the purpose and requirements of individual trials and thefacility to engage directly with research teams. The innovativeness of the solution lies withindeveloping an automated screening tool for selecting patients using data mining. Variouscases of medical treatments in the NHS no longer prove effective for patients. With averagetimelines for innovations in the NHS of 17 years, the improvement of access and availabilityto new treatment trials is vital for increased trials successes and innovations in the NHS.Current trial failures are due to the challenge of recruiting patients resulting in 4 trials out of10 non-completed. With a patient recruitment target of 125,000 per quarter year by 2014, themarket in the UK represents a strong opportunity. The cost of running clinical trials in the UKamounts up to 30% of pharmaceutical companies’ drug development budget, consumingapproximately 40% of total clinical trial costs with time being a prime cause for 70% ofclinical trial failures.While enabling pharmaceutical companies to significantly reduce thecost and time of clinical trials, the platform will encourage patients to take an active role inmanaging their own disease through better education means about their conditions andtreatment availability. With this the project will not only help to meet patient recruitmenttargets on time and costs but improve the opportunities of new treatments and medicalresearch in the UK. The project will deliver direct value to the pharmaceutical sector,benefiting the overall UK healthcare research and economy.